BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Policy

  Roka Bioscience, Inc. Receives AOAC-RI Certification for 10 Additional Salmonella Matrices

  September 27, 2012

   · 

  2 min read
• Drug Development

  Merck & Co., Inc. Drug Shows Promise in Kid’s Aging Disease Study

  September 27, 2012

   · 

  1 min read
• FDA

  Bolton Medical Receives FDA Approval for the Relay® Thoracic Stent-Graft, a Minimally-Invasive Treatment for Thoracic Aortic Aneurysms and Penetrating Ulcers

  September 27, 2012

   · 

  2 min read
• Business

  InSpire MD Co-Founder Hands Back the Corner Office

  September 27, 2012

   · 

  1 min read
• Pharm Country

  IlluminOss Medical Inc. Nabs $28 Million for Bone Angioplasty

  September 27, 2012

   · 

  5 min read
• Deals

  Alphatec Holdings, Inc. Buys Phygen Assets for $15 Million

  September 27, 2012

   · 

  5 min read
• Business

  Eisai Company, Ltd. Partners With the Sabin Vaccine Institute in an Effort to Develop Vaccines for Neglected Tropical Diseases

  September 27, 2012

   · 

  1 min read
• Biotech Beach

  Vital Therapies, Inc. (VTI) Nabs First Closing of $76 Million to Fund Phase 3 Pivotal Clinical Trials of ELAD® in U.S.A. and E.U.

  September 27, 2012

   · 

  5 min read
• Biotech Beach

  BioSpace Spotlights Southern California Life Science Community

  September 27, 2012

   · 

  1 min read
• Business

  Eisai Company Opens New Solid Dose Global Manufacturing Line for Antiepileptic Agent Fycompa® at Its Production Plant in Hatfield, U.K.

  September 27, 2012

   · 

  1 min read